Author:
Silva Abelardo M.,Lee Angela Y.,Erickson John W.,Goldberg Daniel E.
Reference15 articles.
1. WHO (1995) In Control of tropical diseases: malaria control. Geneva, Switzerland, WHO Office of Information.
2. Francis, S. E., Sullivan, D. J. Jr, and Goldberg, D. E. (1997) Ann. Rev. Mircobiol. In press.
3. Francis, S. E., Gluzman, I. Y., Oksman, A., Knickerbocker, A., Mueller, R., Bryant, M., Sherman, D. R., Russell, D. G., and Goldberg, D. E. (1994) EMBO J
13:306–317.
4. Rosenthal, P. J., Wollish, W. S., Palmer, J. T., and Rasnick, D. (1991).J. Clin. Invest.
88:1467–1472.
5. Gluzman, I. Y., Francis, S. E., Oksman, A., Smith, C. E., Duffin, K.L., and Goldberg, D. E. J Clin. Invest (1994) 93:1602–1608.
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Synthesis of 2-aminopyridopyrimidinones and their plasmepsin I, II, IV inhibition potency;Chemistry of Heterocyclic Compounds;2020-06
2. Exploiting Structural Dynamics To Design Open-Flap Inhibitors of Malarial Aspartic Proteases;Journal of Medicinal Chemistry;2019-05-07
3. Flap flexibility amongst plasmepsins I, II, III, IV, and V: Sequence, structural, and molecular dynamics analyses;Proteins: Structure, Function, and Bioinformatics;2015-08-01
4. Fighting Malaria: Structure-Guided Discovery of Nonpeptidomimetic Plasmepsin Inhibitors;Journal of Medicinal Chemistry;2015-03-17
5. Identification of plasmepsin inhibitors as selective anti-malarial agents using ligand based drug design;Bioorganic & Medicinal Chemistry Letters;2011-06